|
|
 |
|
Total Number of Holdings (excluding cash): 50
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
229 |
$80,999.59 |
2.73% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,896 |
$78,822.05 |
2.66% |
| Baxter International Inc. |
BAX |
071813109 |
3,441 |
$77,835.42 |
2.62% |
| LivaNova Plc |
LIVN |
G5509L101 |
940 |
$77,606.40 |
2.62% |
| Revvity, Inc. |
RVTY |
714046109 |
657 |
$73,774.53 |
2.49% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
552 |
$71,815.97 |
2.42% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,577 |
$70,763.02 |
2.39% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
757 |
$69,802.97 |
2.35% |
| DexCom, Inc. |
DXCM |
252131107 |
921 |
$69,038.16 |
2.33% |
| Waters Corporation |
WAT |
941848103 |
184 |
$69,263.12 |
2.33% |
| Agilent Technologies, Inc. |
A |
00846U101 |
513 |
$68,890.77 |
2.32% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,939 |
$67,737.62 |
2.28% |
| Teleflex Incorporated |
TFX |
879369106 |
498 |
$67,593.54 |
2.28% |
| Olympus Corporation |
7733.JP |
J61240107 |
6,040 |
$65,484.52 |
2.21% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
6,834 |
$64,691.33 |
2.18% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
255 |
$64,018.04 |
2.16% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
864 |
$63,452.16 |
2.14% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
211 |
$62,479.21 |
2.11% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
118 |
$62,191.90 |
2.10% |
| Danaher Corporation |
DHR |
235851102 |
310 |
$61,705.50 |
2.08% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
295 |
$61,732.69 |
2.08% |
| Align Technology, Inc. |
ALGN |
016255101 |
340 |
$61,013.00 |
2.06% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
2,616 |
$60,691.35 |
2.05% |
| Terumo Corporation |
4543.JP |
J83173104 |
4,460 |
$60,363.81 |
2.03% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
45 |
$58,327.65 |
1.97% |
| The Cooper Companies, Inc. |
COO |
216648501 |
828 |
$58,539.60 |
1.97% |
| Becton, Dickinson and Company |
BDX |
075887109 |
382 |
$58,041.08 |
1.96% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
633 |
$57,818.22 |
1.95% |
| Steris Plc |
STE |
G8473T100 |
265 |
$57,240.00 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
174 |
$57,381.72 |
1.93% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,073 |
$56,941.08 |
1.92% |
| Medtronic Plc |
MDT |
G5960L103 |
676 |
$56,696.12 |
1.91% |
| Penumbra, Inc. |
PEN |
70975L107 |
178 |
$56,621.80 |
1.91% |
| Abbott Laboratories |
ABT |
002824100 |
588 |
$55,230.84 |
1.86% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
877 |
$53,711.24 |
1.81% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
3,516 |
$53,708.17 |
1.81% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
16,500 |
$53,287.26 |
1.80% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
130 |
$52,881.40 |
1.78% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
514 |
$52,808.36 |
1.78% |
| ResMed Inc. |
RMD |
761152107 |
258 |
$52,598.46 |
1.77% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,332 |
$52,599.96 |
1.77% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
807 |
$52,212.90 |
1.76% |
| Alcon Inc. |
ALC.SW |
H01301128 |
756 |
$50,898.62 |
1.72% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
652 |
$50,927.72 |
1.72% |
| Insulet Corporation |
PODD |
45784P101 |
300 |
$48,384.00 |
1.63% |
| Hoya Corporation |
7741.JP |
J22848105 |
294 |
$45,399.27 |
1.53% |
| BioMerieux |
BIM.FP |
F1149Y232 |
558 |
$44,465.21 |
1.50% |
| Boston Scientific Corporation |
BSX |
101137107 |
955 |
$42,755.35 |
1.44% |
| Cochlear Limited |
COH.AU |
Q25953102 |
484 |
$40,931.25 |
1.38% |
| US Dollar |
$USD |
|
14,464 |
$14,464.20 |
0.49% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|